# Figure Technology Solutions, Inc.: financial statements, quarterly

FIGR · Nasdaq · CIK 2064124 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/figr.md) · [Financials](/companies/figr/financials.md) · [Filings](/companies/figr/filings.md) · [Insiders](/companies/figr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/figr/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [101](/filings/0002064124-25-000032.md) | [83.9 d](/filings/0002064124-26-000009.md) | [84.5](/filings/0002064124-26-000029.md) | [106](/filings/0001628280-26-057061.md) | [156](/filings/0002064124-25-000032.md) | [160 d](/filings/0002064124-26-000009.md) | [167](/filings/0002064124-26-000029.md) | [226](/filings/0001628280-26-057061.md) |
| Research and development | $m | [16.1](/filings/0002064124-25-000032.md) | [16.3 d](/filings/0002064124-26-000009.md) | [17.4](/filings/0002064124-26-000029.md) | [16.0](/filings/0001628280-26-057061.md) | [15.9](/filings/0002064124-25-000032.md) | [15.6 d](/filings/0002064124-26-000009.md) | [15.6](/filings/0002064124-26-000029.md) | [15.6](/filings/0001628280-26-057061.md) |
| Operating income | $m | [26.1](/filings/0002064124-25-000032.md) | [(0.8) d](/filings/0002064124-26-000009.md) | [8.1](/filings/0002064124-26-000029.md) | [27.7](/filings/0001628280-26-057061.md) | [52.7](/filings/0002064124-25-000032.md) | [29.0 d](/filings/0002064124-26-000009.md) | [41.9](/filings/0002064124-26-000029.md) | [77.7](/filings/0001628280-26-057061.md) |
| Income tax | $m | [1.3](/filings/0002064124-25-000032.md) | [0.4 d](/filings/0002064124-26-000009.md) | [1.2](/filings/0002064124-26-000029.md) | [3.4](/filings/0001628280-26-057061.md) | [(31.5)](/filings/0002064124-25-000032.md) | [6.3 d](/filings/0002064124-26-000009.md) | [(6.9)](/filings/0002064124-26-000029.md) | [(4.4)](/filings/0001628280-26-057061.md) |
| Net income | $m | [27.3](/filings/0002064124-25-000032.md) | [5.5 d](/filings/0002064124-26-000009.md) | [(0.8)](/filings/0002064124-26-000029.md) | [29.9](/filings/0001628280-26-057061.md) | [89.6](/filings/0002064124-25-000032.md) | [15.2 d](/filings/0002064124-26-000009.md) | [44.9](/filings/0002064124-26-000029.md) | [87.4](/filings/0001628280-26-057061.md) |
| Diluted EPS | $ per share | [0.09](/filings/0002064124-25-000032.md) | not reported | [(0.01)](/filings/0002064124-26-000029.md) | [0.08](/filings/0001628280-26-057061.md) | [0.34](/filings/0002064124-25-000032.md) | not reported | [0.18](/filings/0002064124-26-000029.md) | [0.35](/filings/0001628280-26-057061.md) |
| Basic EPS | $ per share | [0.09](/filings/0002064124-25-000032.md) | not reported | [(0.01)](/filings/0002064124-26-000029.md) | [0.11](/filings/0001628280-26-057061.md) | [0.42](/filings/0002064124-25-000032.md) | not reported | [0.21](/filings/0002064124-26-000029.md) | [0.39](/filings/0001628280-26-057061.md) |

- Revenue: us-gaap:Revenues
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | [290](/filings/0002064124-26-000009.md) | not reported | not reported | [1,097](/filings/0002064124-25-000032.md) | [1,198](/filings/0001628280-26-057061.md) | [1,465](/filings/0002064124-26-000029.md) | [1,438](/filings/0001628280-26-057061.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | [855](/filings/0002064124-26-000009.md) | not reported | not reported | [1,760](/filings/0002064124-25-000032.md) | [1,861](/filings/0001628280-26-057061.md) | [2,226](/filings/0002064124-26-000029.md) | [2,392](/filings/0001628280-26-057061.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | [1,160](/filings/0002064124-26-000009.md) | not reported | not reported | [2,157](/filings/0002064124-25-000032.md) | [2,318](/filings/0001628280-26-057061.md) | [2,731](/filings/0002064124-26-000029.md) | [3,018](/filings/0001628280-26-057061.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | [626](/filings/0002064124-26-000009.md) | not reported | not reported | [778](/filings/0002064124-25-000032.md) | [846](/filings/0001628280-26-057061.md) | [1,173](/filings/0002064124-26-000029.md) | [1,285](/filings/0001628280-26-057061.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [796](/filings/0002064124-26-000009.md) | not reported | not reported | [980](/filings/0002064124-25-000032.md) | [1,080](/filings/0001628280-26-057061.md) | [1,439](/filings/0002064124-26-000029.md) | [1,605](/filings/0001628280-26-057061.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | [168](/filings/0002064124-26-000009.md) | not reported | not reported | [198](/filings/0002064124-25-000032.md) | [230](/filings/0001628280-26-057061.md) | [262](/filings/0002064124-26-000029.md) | [316](/filings/0001628280-26-057061.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | [305](/filings/0002064124-25-000032.md) | not reported | not reported | [269](/filings/0002064124-25-000032.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | [260](/filings/0002064124-26-000009.md) | [222](/filings/0002064124-26-000009.md) | [303](/filings/0002064124-25-000032.md) | [350](/filings/0002064124-25-000032.md) | [355](/filings/0002064124-26-000009.md) | [369](/filings/0001628280-26-057061.md) | [404](/filings/0001628280-26-057061.md) | [1,168](/filings/0002064124-25-000032.md) | [1,229](/filings/0001628280-26-057061.md) | [1,292](/filings/0002064124-26-000029.md) | [1,413](/filings/0001628280-26-057061.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [87.4 d](/filings/0002064124-26-000009.md) | [(140)](/filings/0002064124-26-000029.md) | [216 d](/filings/0001628280-26-057061.md) | [(26.8) d](/filings/0002064124-25-000032.md) | [13.3 d](/filings/0002064124-26-000009.md) | [(37.8)](/filings/0002064124-26-000029.md) | [(35.2) d](/filings/0001628280-26-057061.md) |
| Share repurchases | $m | not reported | [0.0](/filings/0002064124-26-000029.md) | [0.0 d](/filings/0001628280-26-057061.md) | not reported | not reported | [9.7](/filings/0002064124-26-000029.md) | [0.0 d](/filings/0001628280-26-057061.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [73.6](/filings/0002064124-25-000032.md) | [69.4](/filings/0002064124-26-000029.md) | [87.8](/filings/0001628280-26-057061.md) | [130](/filings/0002064124-25-000032.md) | [249](/filings/0002064124-26-000029.md) | [247](/filings/0001628280-26-057061.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.